All investigators have primary ongoing responsibility for the health and well-being of subjects.
Each investigator must respect the rights of subjects to be treated with dignity, respect, justice, and the intent not to harm throughout the research study. If harm to the subject could result from suddenly withdrawing from the study, such information must be given to the subject. FDA regulations must be observed if an investigational drug or device is involved. Hospital reporting requirements must be observed. The HSRC may monitor studies at its discretion.